Aventis: New Drug Application for the Treatment of Viral Respiratory Infection (VRI, or the Common Cold)
Picovir™ (pleconaril) to be Reviewed by FDA Antiviral Drugs Advisory Committee on March 19, 2002
08-Feb-2002 -
Aventis Pharmaceuticals
Exton, PA, and Bridgewater, N.J., February 7, 2002 – ViroPharma Incorporated (Nasdaq: VPHM) and Aventis Pharmaceuticals, the U.S. pharmaceutical company of Aventis Pharma AG, today announced that the new drug application for Picovir™ (pleconaril), an investigational ...
Aventis
diseases
drug development
+4